» Authors » Daniela Buhl

Daniela Buhl

Explore the profile of Daniela Buhl including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 146
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanak F, Faes L, Eppenberger L, Baenninger P, Kaufmann C, Golla K, et al.
Klin Monbl Augenheilkd . 2022 Apr; 239(4):605-609. PMID: 35472816
Background: Switzerland was strongly affected by the pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in a nationwide lockdown in March 2020. Ophthalmologists were at most risk...
2.
Sanak F, Baenninger P, Iselin K, Kaufmann C, Bachmann L, Buhl D, et al.
Klin Monbl Augenheilkd . 2022 Apr; 239(4):378-381. PMID: 35472775
Background: Vascular endothelial growth factor (VEGF)-A, the most abundant subtype of the VEGF family in the eye, plays an important role in corneal homeostasis due to its ability to mediate...
3.
Sanak F, Baenninger P, Kaufmann C, Iselin K, Bachmann L, Buhl D, et al.
Klin Monbl Augenheilkd . 2021 Apr; 238(4):346-348. PMID: 33930907
Background: There are a variety of protocols for manufacturing autologous serum (AS) eye drops. The Lucerne protocol for the production of AS eye drops uses a slightly reduced gravitational (g)-force...
4.
Speich C, Wegmuller R, Brittenham G, Zeder C, Cercamondi C, Buhl D, et al.
Br J Haematol . 2020 Aug; 192(1):179-189. PMID: 32862453
We report the first measurements of long-term iron absorption and loss during iron supplementation in African children using a stable isotope of iron ( Fe). After uniform labelling of body...
5.
De Marchis G, Dankowski T, Konig I, Fladt J, Fluri F, Gensicke H, et al.
Neurology . 2019 Mar; 92(13):e1517-e1525. PMID: 30824558
Objectives: To derive and externally validate a copeptin-based parsimonious score to predict unfavorable outcome 3 months after an acute ischemic stroke (AIS). Methods: The derivation cohort consisted of patients with...
6.
De Marchis G, Weck A, Audebert H, Benik S, Foerch C, Buhl D, et al.
Stroke . 2014 Aug; 45(10):2918-23. PMID: 25169950
Background And Purpose: Copeptin has been associated with recurrent cerebrovascular events after transient ischemic attack (TIA). In an independent cohort, we evaluated copeptin for the prediction of recurrent cerebrovascular events...
7.
De Marchis G, Katan M, Weck A, Fluri F, Foerch C, Findling O, et al.
Neurology . 2013 Mar; 80(14):1278-86. PMID: 23468541
Objective: To evaluate and validate the incremental value of copeptin in the prediction of outcome and complications as compared with established clinical variables. Methods: In this prospective, multicenter, cohort study,...
8.
Arampatzis S, Frauchiger B, Fiedler G, Leichtle A, Buhl D, Schwarz C, et al.
Am J Med . 2012 Sep; 125(11):1125.e1-1125.e7. PMID: 22939097
Objective: Dysnatremias are common in critically ill patients and associated with adverse outcomes, but their incidence, nature, and treatment rarely have been studied systematically in the population presenting to the...
9.
De Marchis G, Katan M, Weck A, Brekenfeld C, Mattle H, Buhl D, et al.
Int J Stroke . 2012 Feb; 8(3):214-8. PMID: 22336226
Rationale: Copeptin independently predicts functional outcome and mortality at 90 days and one-year after ischemic stroke. In patients with transient ischemic attack, elevated copeptin values indicate an increased risk of...
10.
Arampatzis S, Exadaktylos A, Buhl D, Zimmermann H, Lindner G
Wien Klin Wochenschr . 2011 Dec; 124(5-6):181-3. PMID: 22183815
Background: Hypo- and hypernatraemia are the most common electrolyte disorders in hospitalized patients and have been associated with increased mortality. However, data on the prevalence of dysnatraemias in the emergency...